Sarah Aschenbrenner

Munich Allemagne

Prix à l'honneur

JUVE Awards 2023

Law firm of the year for IP Law

Sarah advises national and international companies in the pharmaceutical, medical device and biotech industry on all regulatory and contractual matters.

Coffee Break Life Sciences Start-ups | Our new webinar series

Every third Wednesday of the month in 2024.

CV

Since 2023 Associate, Taylor Wessing

2022 - 2023 Associate, Fieldfisher

Carrière

Since 2023 Associate, Taylor Wessing

2022 - 2023 Associate, Fieldfisher

Formation

2022 Admitted as a lawyer

2021 Second state examination, Munich

2019 - 2021 Legal clerkship, Higher Regional Court of Munich

Langues étrangères

Prix et distinctions

JUVE Awards 2023

Featured

Actualités et publications récentes

View Sarah 's insights

Cliquer ici pour en savoir plus

Sciences de la vie et Santé

Regulatory Update: Microplastics and Medical Devices

18 septembre 2024

par Sarah Aschenbrenner

Sciences de la vie et Santé

Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8

22 août 2024

In-depth analysis

par Sarah Aschenbrenner

Cliquer ici pour en savoir plus

Sciences de la vie et Santé

Gender Data Gap and Femtech: A Legal Perspective

6 juin 2024

Briefing

par Dr. Stefanie Greifeneder et Sarah Aschenbrenner

Cliquer ici pour en savoir plus

Sarah Aschenbrenner

JUVE Awards 2023

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

JUVE Awards 2023

Actualités et publications récentes

Regulatory Update: Microplastics and Medical Devices

Sarah Aschenbrenner

JUVE Awards 2023

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

JUVE Awards 2023

Actualités et publications récentes

Regulatory Update: Microplastics and Medical Devices

Related news & insights

Affaire Illumina-Grail – Quand le pragmatisme économique se heurte à la sécurité juridique

Biopharma partnering monthly update: August 2024

Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9

Licensing the Cabilly antibody manufacturing patents: are royalties payable on post-expiry sales?

Artificial Intelligence and Patent Law

Higher Regional Court of Hamburg: On the risk classification of health apps

Higher Regional Court of Nuremberg: In principle, no loss of urgency due to the full utilisation of legal deadlines

European Court of Justice on advertising for biocidal products: ‘Skin-friendly’ is misleading and violates EU law

Regional Court of Hamburg: Prohibition of a bonus programme for nursing staff because of violation of Section 7 para. 1 sentence 1 of the German Drug Advertising Act (HWG)

Federal Social Court (BSG): Priority of drug safety even in the treatment of regularly fatal diseases

Autres avocats qui pourraient vous intéresser